These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28988591)

  • 1. Bullous Skin Lesions in a Patient with End-Stage Renal Disease and Hepatitis C.
    Strauss MM; Shetty A; Witheiler D
    Adv Perit Dial; 2016; 32():56-60. PubMed ID: 28988591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].
    Muray S; Casanova JM; Marco MP; Craver L; Martín M; Fernández E
    Nefrologia; 2002; 22(6):570-3. PubMed ID: 12516291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
    Chan OT; Tsai N; Wong RL; Izumi AK
    Cutis; 2006 Dec; 78(6):397-400. PubMed ID: 17243426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyria cutanea tarda occurring in a patient with renal failure, systemic lupus erythematosus and chronic hepatitis C infection treated with hemodialysis.
    Lee PK; Abrahams I; Bickers DR
    Cutis; 1999 Oct; 64(4):237-9. PubMed ID: 10544877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyria cutanea tarda in a hemodialysis patient with hepatitis C virus: efficacy of treatment with multiple phlebotomies and erythropoietin.
    Hamzi MA; Alayoud A; Asseraji M; Akhmouch I; Oualim Z
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):121-3. PubMed ID: 23354206
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of porphyria cutanea tarda with phlebotomy in a patient on peritoneal dialysis.
    Kelly MA; O'Rourke KD
    J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):336-8. PubMed ID: 11174409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous lesions in a haemodialysis patient.
    Loon JCH; Han T; Thet Z
    Nephrology (Carlton); 2017 Oct; 22(10):822-823. PubMed ID: 28921752
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review.
    Shieh S; Cohen JL; Lim HW
    J Am Acad Dermatol; 2000 Apr; 42(4):645-52. PubMed ID: 10727312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: a case report.
    Tarwater K; Misra S; Misra M
    Hemodial Int; 2008 Oct; 12 Suppl 2():S38-42. PubMed ID: 18837769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Porphyria cutanea tarda in a long-term hemodialysis patient].
    Földes M; Kószó F; Kis E; Judák R; Dobozy A
    Hautarzt; 1996 Dec; 47(12):932-5. PubMed ID: 9081942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda, hepatitis C infection, and iron overload in a patient on hemodialysis.
    Albitar S; Bourgeon B; Chuet C
    Am J Med; 1999 Feb; 106(2):266-7. PubMed ID: 10230760
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of available intravenous iron preparations in hemodialysis.
    Palmer K; Cameron K; Battistella M
    CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
    [No Abstract]   [Full Text] [Related]  

  • 13. Porphyria cutanea tarda in a chronic hemodialysis patient.
    Labidi J
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):919-22. PubMed ID: 20814132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda. Don't forget to look at the urine.
    Rich MW
    Postgrad Med; 1999 Apr; 105(4):208-10, 213-4. PubMed ID: 10223097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda in a hemodialysis patient.
    Huang YC; Wang CC; Sue YM
    QJM; 2013 Jun; 106(6):591-2. PubMed ID: 22753666
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
    Barbieri C; Bolzoni E; Mari F; Cattinelli I; Bellocchio F; Martin JD; Amato C; Stopper A; Gatti E; Macdougall IC; Stuard S; Canaud B
    PLoS One; 2016; 11(3):e0148938. PubMed ID: 26939055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous skin lesions in a patient undergoing chronic hemodialysis.
    Ryali ME; Whittier WL
    Semin Dial; 2010; 23(1):83-7. PubMed ID: 20331820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis.
    Ruggian JC; Fishbane S; Demento FJ; Maesaka JK; Frei GL
    J Am Soc Nephrol; 1996 Mar; 7(3):397-402. PubMed ID: 8704104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.
    Rostoker G; Griuncelli M; Loridon C; Couprie R; Benmaadi A; Bounhiol C; Roy M; Machado G; Janklewicz P; Drahi G; Dahan H; Cohen Y
    Am J Med; 2012 Oct; 125(10):991-999.e1. PubMed ID: 22998881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.